官方服务：
资源简介：
RNA sequencing of A431 squamous carcinoma cell line treated with Cetuximab and Erlotinib
应用场景：
创建时间：
2023-05-04
相关数据集
Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-Longterm-HCC1954-SKBR3]
EGFR-inhibition is required for targeted therapies of ERBB2-positive/EGFR high breast cancer. Approximately 30% of human ERBB2-positive breast tumors also express EGFR. Three therapeutics were analyze
NIAID Data Ecosystem70
Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash. Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash
Dermal fibroblasts that were cultured from skin biopsy samples were treated for three days with either 1µM of erlotinib, 1µM of DMSO (vehicle), or no treatment. The cells were harvested on the fourth
NIAID Data Ecosystem60
Comparative performance of existing method with our method developing for predicting inhibitors against wild type EGFR inhibitors.
Comparative performance of existing method with our method developing for predicting inhibitors against wild type EGFR inhibitors.
NIAID Data Ecosystem30
Host-dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors. Host-dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors
RNA-Seq comparison of Dacomitinib resistant PC9 lung adenocarcinoma cells vs the parental cells. Overall design: PC9 cells were treated with increasing concentration of dacomitinib (from 1 pM to 100 n
NIAID Data Ecosystem60
Synthesis of some quinazolinones inspired from the natural alkaloid L - norephedrine as EGFR inhibitors and radiosensitizers
A set of quinazolinones synthesized by the aid of L-norephedrine was assembled to generate novel analogues as potential anticancer and radiosensitizing agents. The new compounds were evaluated for the
NIAID Data Ecosystem60
